Investor mix
9 investors on record; lead investors include Morningside.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 67% |
| Accelerator & incubator | 1 | 11% |
| Other / undisclosed | 2 | 22% |
Oncolytic virus platform for treating malignant glioma.
9 investors on record; lead investors include Morningside.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 67% |
| Accelerator & incubator | 1 | 11% |
| Other / undisclosed | 2 | 22% |